Hannah Joseph Hospital Limited, a prominent healthcare provider in South Tamil Nadu, is hitting the capital markets on January 22, 2026. The IPO is a 100% fresh issue of 60 lakh shares. The company has fixed a price band of ₹67 to ₹70 per share.
The hospital, which started as a neurology center in 2008, currently operates a 150-bed tertiary care facility. The proceeds from the IPO (₹34.98 crore) are primarily earmarked for establishing a new Radiation Oncology Centre to provide integrated cancer care, including targeted therapies and chemotherapy.
Financially, the company has shown strong momentum, with its Profit After Tax (PAT) growing from ₹1.01 crore in FY23 to ₹7.21 crore in FY25. As of today, Wednesday, January 21, 2026, the Grey Market Premium (GMP) is trading at ₹0, indicating a neutral market sentiment with expectations of a listing "at par" with the issue price.
Key IPO Details & Timetable
| Feature | Details |
|---|---|
| Price Band | ₹67 – ₹70 per share |
| Lot Size | 1,500 Shares (Min. Investment ₹2,10,000 for Retail*) |
| Issue Size | ₹42.00 Crore (100% Fresh Issue) |
| Listing Platform | BSE SME |
| Anchor Bidding | January 21, 2026 (Today) |
| Open Date | January 22, 2026 (Tomorrow) |
| Close Date | January 27, 2026 |
| Basis of Allotment | January 28, 2026 |
| Tentative Listing | January 30, 2026 |
*Note: Retail investors are required to apply for a minimum of 2 lots (3,000 shares) for this specific issue.
Important Note for Investors
Specialized Niche: The hospital is a leading referral center for complex neurosurgery and cardiac procedures in South Tamil Nadu, holding both NABH and NABL accreditations.
Expansion Risks: A significant portion of the IPO funds is for a new Oncology Centre. However, the company is yet to place orders for medical equipment or receive final government approvals for this facility, which could lead to implementation delays.
Geographical Concentration: Like many regional healthcare players, 100% of its revenue comes from its single location in Madurai, making it sensitive to local competition and regional economic shifts.
Financial Health: While revenue has surged (CAGR of 19.31%), the company currently has a bed occupancy rate of roughly 38% (as of Sept 2025), suggesting there is significant room to grow revenue through better utilization of existing infrastructure.